Skip to main content
. 2021 Jun 9;10:184. Originally published 2021 Mar 5. [Version 2] doi: 10.12688/f1000research.51208.2

Table 2. Correlations between ACE activity with anthropometric data, muscle function characteristics and functional performance in men taking/not taking ACEI and taking/not taking ASBMs.

Characteristics ACEI
(n=26)
non ACEI
(n=53)
ASBMs
(n=34)
non ASBMs
(n=45)
all
(n=79)
Age (years) Rho=0.16
P=0.4
Rho=0.38
P=0.006
Rho=0.19
P=0.27
Rho=0.38
P=0.01
Rho=0.26
P=0.02
Body mass (kg) Rho=-0.15
P=0.45
Rho=0.17
P=0.23
Rho=-0.04
P=0.80
Rho=0.12
P=0.42
Rho=0.04
P=0.7
Body mass index (kg·m -2) Rho=0.01
P=0.95
Rho=0.10
P=0.46
Rho=0.10
P=0.56
Rho=0.04
P=0.81
Rho=0.02
P=0.84
Medications (number) Rho=0.24
P=0.24
Rho=0.09
P=0.50
Rho=0.17
P=0.33
Rho=0.001
P=0.99
Rho=0.03
P=0.77
Fat percentage of body mass (%) Rho=-0.21
P=0.31
Rho=0.19
P=0.19
Rho=-0.07
P=0.70
Rho=0.14
P=0.38
Rho=0.04
P=0.75
Left handgrip strength (kg) Rho=-0.40
P=0.087
Rho=-0.22
P=0.12
Rho=-0.29
P=0.10
Rho=-0.21
P=0.18
Rho=-0.22
P=0.06
Right handgrip strength (kg) Rho=-0.18
P=0.38
Rho=-0.14
P=0.32
Rho=-0.08
P=0.64
Rho=-0.15
P=0.32
Rho=-0.12
P=0.29
Pmax (W·kg -1) Rho=-0.19
P=0.34
Rho=-0.29
P=0.04
Rho=-0.14
P=0.42
Rho=-0.29
P=0.06
Rho=-0.21
P=0.06
Ʋopt (rep/min) Rho=-0.15
P=0.45
Rho=-0.31
p=0.03
Rho=-0.16
P=0.35
Rho=-0.31
P=0.04
Rho=-0.22
P=0.05
ADL Rho=-0.22
P=0.27
Rho=-0.04
P=0.76
Rho=-0.18
P=0.31
Rho=-0.002
P=0.99
Rho=-0.06
P=0.58
IADL Rho=0.06
P=0.77
Rho=-0.07
P=0.60
Rho=0.18
P=0.29
Rho=-0.09
P=0.54
Rho=0.09
P=0.42
TUG (s) Rho=-0.04
P=0.85
Rho=-0.12
P=0.39
Rho=-0.13
P=0.46
Rho=-0.11
P=0.47
Rho=-0.13
P=0.27

Abbreviations: Pmax, maximum power; Ʋopt, optimal shortening velocity of the knee extensor muscles; ACE, angiotensin-converting enzyme; ACEI, Angiotensin Converting Enzyme Inhibitors; ASBMs, angiotensin system blocking medications; TUG, Timed Up and Go test; ACEI - men taking ACEI; non ACEI – men not taking ACEI; ASBMs - men taking ASBMs; non ASBMs - men not taking ASBMs